Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Kazuhiro Shibayama Takatoshi Takubo Nozomu Fuse Toshihiko Doi Narikazu Boku Takayuki Yoshino Junichiro Watanabe Atsushi Ohtsu |
| Publication date | July 19, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |